5,554 reports of this reaction
5.0% of all ETONOGESTREL reports
#2 most reported adverse reaction
PRODUCT QUALITY ISSUE is the #2 most commonly reported adverse reaction for ETONOGESTREL, manufactured by Organon LLC. There are 5,554 FDA adverse event reports linking ETONOGESTREL to PRODUCT QUALITY ISSUE. This represents approximately 5.0% of all 110,074 adverse event reports for this drug.
Patients taking ETONOGESTREL who experience product quality issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT QUALITY ISSUE is moderately reported among ETONOGESTREL users, representing a notable but not dominant share of adverse events.
In addition to product quality issue, the following adverse reactions have been reported for ETONOGESTREL:
The following drugs have also been linked to product quality issue in FDA adverse event reports:
PRODUCT QUALITY ISSUE has been reported as an adverse event in 5,554 FDA reports for ETONOGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT QUALITY ISSUE accounts for approximately 5.0% of all adverse event reports for ETONOGESTREL, making it one of the most commonly reported side effect.
If you experience product quality issue while taking ETONOGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.